Everything tagged "healthcare plans" across the TickerSpark archives.
5 articles
Humana is a medium-term recovery story with scale in Medicare Advantage and a growing CenterWell platform, but near-term margins remain pressured. The report rates the stock Hold as management works toward a 2028 margin reset.
Centene is showing real margin-recovery progress after a difficult 2025, but Medicaid, Marketplace, and Medicare cost pressure still make this a Hold. Q1 2026 results and raised guidance support the turnaround, though the stock already trades near consensus value.
Molina Healthcare is a large government-sponsored managed care franchise with a strong balance sheet and a clear growth pipeline, but recent earnings have been pressured by medical cost inflation and contract churn. The report rates MOH a Buy, with upside tied to a recovery in margins and execution on Medicaid, Medicare, and Florida.
UnitedHealth is showing a real earnings recovery, with Q2 2026 revenue of $112.0B and adjusted EPS of $6.38, but the stock still trades at a premium that leaves less room for execution mistakes.
Elevance Health is working through a Medicaid-driven margin reset, but Q2 results, raised guidance, and Carelon growth point to a resilient earnings recovery. The stock looks attractively valued for a large managed-care platform with scale, cash flow, and multiple growth levers.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime